LENZ
Price
$25.45
Change
+$0.27 (+1.07%)
Updated
Jan 30, 04:59 PM (EDT)
Capitalization
692.47M
TCRX
Price
$2.59
Change
+$0.09 (+3.60%)
Updated
Jan 30, 04:59 PM (EDT)
Capitalization
141.26M
33 days until earnings call
Ad is loading...

LENZ vs TCRX

Header iconLENZ vs TCRX Comparison
Open Charts LENZ vs TCRXBanner chart's image
LENZ Therapeutics
Price$25.45
Change+$0.27 (+1.07%)
Volume$2.21K
Capitalization692.47M
TScan Therapeutics
Price$2.59
Change+$0.09 (+3.60%)
Volume$6.89K
Capitalization141.26M
LENZ vs TCRX Comparison Chart
Loading...
LENZ
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
TCRX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
LENZ vs. TCRX commentary
Jan 31, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is LENZ is a StrongBuy and TCRX is a StrongBuy.

Ad is loading...
COMPARISON
Comparison
Jan 31, 2025
Stock price -- (LENZ: $25.48 vs. TCRX: $2.58)
Brand notoriety: LENZ and TCRX are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: LENZ: 53% vs. TCRX: 32%
Market capitalization -- LENZ: $692.47M vs. TCRX: $141.26M
LENZ [@Biotechnology] is valued at $692.47M. TCRX’s [@Biotechnology] market capitalization is $141.26M. The market cap for tickers in the [@Biotechnology] industry ranges from $379.55B to $0. The average market capitalization across the [@Biotechnology] industry is $2.47B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

LENZ’s FA Score shows that 0 FA rating(s) are green whileTCRX’s FA Score has 1 green FA rating(s).

  • LENZ’s FA Score: 0 green, 5 red.
  • TCRX’s FA Score: 1 green, 4 red.
According to our system of comparison, LENZ is a better buy in the long-term than TCRX.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

LENZ’s TA Score shows that 5 TA indicator(s) are bullish while TCRX’s TA Score has 5 bullish TA indicator(s).

  • LENZ’s TA Score: 5 bullish, 3 bearish.
  • TCRX’s TA Score: 5 bullish, 3 bearish.
According to our system of comparison, both LENZ and TCRX are a good buy in the short-term.

Price Growth

LENZ (@Biotechnology) experienced а +2.91% price change this week, while TCRX (@Biotechnology) price change was +0.78% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -1.11%. For the same industry, the average monthly price growth was +1.05%, and the average quarterly price growth was +4.49%.

Reported Earning Dates

LENZ is expected to report earnings on May 09, 2024.

TCRX is expected to report earnings on May 13, 2025.

Industries' Descriptions

@Biotechnology (-1.11% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
LENZ($692M) has a higher market cap than TCRX($141M). LENZ YTD gains are higher at: -11.742 vs. TCRX (-15.132). TCRX has more cash in the bank: 271M vs. LENZ (217M). LENZ has less debt than TCRX: LENZ (1.58M) vs TCRX (90.4M).
LENZTCRXLENZ / TCRX
Capitalization692M141M491%
EBITDAN/A-102.91M-
Gain YTD-11.742-15.13278%
P/E RatioN/AN/A-
RevenueN/A9.36M-
Total Cash217M271M80%
Total Debt1.58M90.4M2%
TECHNICAL ANALYSIS
Technical Analysis
LENZTCRX
RSI
ODDS (%)
Bullish Trend 3 days ago
90%
Bullish Trend 3 days ago
84%
Stochastic
ODDS (%)
Bearish Trend 3 days ago
80%
Bullish Trend 3 days ago
84%
Momentum
ODDS (%)
Bullish Trend 3 days ago
75%
Bearish Trend 3 days ago
85%
MACD
ODDS (%)
Bullish Trend 3 days ago
79%
Bullish Trend 3 days ago
86%
TrendWeek
ODDS (%)
Bullish Trend 3 days ago
81%
Bearish Trend 3 days ago
89%
TrendMonth
ODDS (%)
Bearish Trend 3 days ago
83%
Bearish Trend 3 days ago
89%
Advances
ODDS (%)
Bullish Trend 4 days ago
82%
Bullish Trend 3 days ago
81%
Declines
ODDS (%)
Bearish Trend 24 days ago
83%
Bearish Trend 5 days ago
90%
BollingerBands
ODDS (%)
Bullish Trend 3 days ago
58%
Bullish Trend 3 days ago
90%
Aroon
ODDS (%)
Bearish Trend 3 days ago
88%
Bearish Trend 3 days ago
89%
View a ticker or compare two or three
Ad is loading...
LENZ
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
TCRX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
TVIFX86.591.39
+1.63%
Thornburg Small/Mid Cap Core I
GRMRX28.010.15
+0.54%
Nationwide S&P 500 Index R
ENPSX35.64N/A
N/A
ProFunds UltraSector Energy Svc
FASGX27.98N/A
N/A
Fidelity Asset Manager 70%
AIBBX15.86N/A
N/A
Aristotle Small Cap Equity I-2

LENZ and

Correlation & Price change

A.I.dvisor indicates that over the last year, LENZ has been loosely correlated with IVVD. These tickers have moved in lockstep 36% of the time. This A.I.-generated data suggests there is some statistical probability that if LENZ jumps, then IVVD could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To LENZ
1D Price
Change %
LENZ100%
+1.19%
IVVD - LENZ
36%
Loosely correlated
+1.22%
DNTH - LENZ
28%
Poorly correlated
+4.36%
TCRX - LENZ
26%
Poorly correlated
+3.20%
DSGN - LENZ
26%
Poorly correlated
+0.61%
OCGN - LENZ
25%
Poorly correlated
+3.97%
More

TCRX and

Correlation & Price change

A.I.dvisor indicates that over the last year, TCRX has been loosely correlated with CRVO. These tickers have moved in lockstep 41% of the time. This A.I.-generated data suggests there is some statistical probability that if TCRX jumps, then CRVO could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To TCRX
1D Price
Change %
TCRX100%
+3.20%
CRVO - TCRX
41%
Loosely correlated
-1.32%
PRME - TCRX
40%
Loosely correlated
+2.91%
ALLO - TCRX
40%
Loosely correlated
+4.35%
STRO - TCRX
39%
Loosely correlated
+3.72%
IMNM - TCRX
39%
Loosely correlated
+12.41%
More